<progress id="drqnt"><track id="drqnt"></track></progress><var id="drqnt"><source id="drqnt"><meter id="drqnt"></meter></source></var>
  1. <button id="drqnt"><object id="drqnt"></object></button>

          <button id="drqnt"><object id="drqnt"></object></button>
        1. <button id="drqnt"><acronym id="drqnt"></acronym></button><dd id="drqnt"><pre id="drqnt"></pre></dd>
          <em id="drqnt"><ruby id="drqnt"><u id="drqnt"></u></ruby></em>
          1. <dd id="drqnt"><noscript id="drqnt"></noscript></dd>
            <li id="drqnt"></li>
            1. <legend id="drqnt"></legend>

              Recombinant protein products

              Name Mouse GM-CSF / CSF2 Protein/重組小鼠 GM-CSF / CSF2
              Specifications 20ug
              Serial number CZDB-002
              The price Inquiry
              Chinese name 重組小鼠 GM-CSF / CSF2 蛋白
              Molecular nickname AI661682, ATAC, LTN, Lptn, SCM-1, SCM-1a, Scyc1
              Molecular species Mouse
              Express label His,S
              Express the host E. coli
              Concentration > 95 % as determined by SDS-PAGE
              Buffer Lyophilized from sterile PBS, pH 7.4
              Storage conditions -70°C,應避免反復凍融。
              Basic description Granulocyte-macrophage colony-stimulating factor (GM-CSF) is one of an array of cytokines with pivotal roles in embryo implantation and subsequent development. Several cell lineages in the reproductive tract and gestational tissues synthesise GM-CSF under direction by ovarian steroid hormones and signalling agents originating in male seminal fluid and the conceptus. The pre-implantation embryo, invading placental trophoblast cells and the abundant populations of leukocytes controlling maternal immune tolerance are all subject to GM-CSF regulation. GM-CSF stimulates the differentiation of hematopoietic progenitors to monocytes and neutrophils, and reduces the risk for febrile neutropenia in cancer patients. GM-CSF also has been shown to induce the differentiation of myeloid dendritic cells (DCs) that promote the development of T-helper type 1 (cellular) immune responses in cognate T cells. The active form of the protein is found extracellularly as a homodimer, and the encoding gene is localized to a related gene cluster at chromosome region 5q31 which is known to be associated with 5q-syndrome and acute myelogenous leukemia. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has been utilized in the clinical management of multiple disease processes. Most recently, GM-CSF has been incorporated into the treatment of malignancies as a sole therapy, as well as a vaccine adjuvant. While the benefits of GM-CSF in this arena have been promising, recent reports have suggested the potential for GM-CSF to induce immune suppression and, thus, negatively impact outcomes in the management of cancer patients. GM-CSF deficiency in pregnancy adversely impacts fetal and placental development, as well as progeny viability and growth after birth, highlighting this cytokine as a central maternal determinant of pregnancy outcome with clinical relevance in human fertility.

              Collect from
              ?
              鄂ICP備19022221號-2 Trigoats Co., Ltd.